Navigation Links
American Oriental Bioengineering, Inc. to Report Second Quarter 2008 Financial Results
Date:7/24/2008

NEW YORK, July 24 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB) today announced that it plans to release second quarter 2008 financial results on Monday, August 11, 2008, after the market closes.

The Company will hold a conference call at 5:00 pm ET on August 11, 2008 to discuss its fiscal second quarter 2008 results. Listeners may access the call by dialing 1-800-599-9816 or 1-617-847-8705 for international callers, access code: 41757592. A webcast will also be available through AOB's website at http://www.bioaobo.com . A replay of the call will be available through August 18, 2008. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 95123746.

About American Oriental Bioengineering

American Oriental Bioengineering (NYSE: AOB) is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Companys North American Headquarters
2. American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes
3. American Telugu Association's Convention Attracts Over 10,000 People in the U.S.
4. Covert Torture, Surveillance Jeopardizes the Freedom of American Citizens
5. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
6. 17th Annual Congress on Womens Health To Be Held March 27-29, 2009 in Collaboration with American Medical Womens Association (AMWA)
7. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
8. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer
9. American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering
10. American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock
11. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Today, TiFiber, Inc. ... production facility and future company headquarters in Fort ... new materials that safely and effectively control dangerous ... of its historic, strong support for manufacturing, but ... leading edge, technology-based companies such as TiFiber. ...
(Date:12/19/2014)... Biddeford, ME (PRWEB) December 18, 2014 ... founding director of the Center for Excellence in the ... of New England, has been selected as a member ... He is the first neuroscientist from Maine to receive ... a nonprofit organization supported entirely by the Dana Foundation. ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... to the rising ageing population and technological innovations ... and nutraceutical industries are catalysing the growth of ... @ http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report ... as well as new entrants/smaller firms to gauge ...
Breaking Biology Technology:Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4
... Nov. 5, 2011 Jennerex, Inc., a private clinical-stage ... of first-in-class targeted oncolytic products for cancer, today presented ... trial of JX-594 in patients with advanced liver cancer ... the high JX-594 dose group versus the low dose ...
... Corporation (OTCQX:RXPC) (OTCPK:RXPC), a developer and marketer of ... that all six proxy resolutions passed at a special ... statement was filed with the Securities and Exchange Commission ... and on the Company,s web site:   www.radient-pharma.com ...
... ZURICH, Switzerland, November 4, 2011 Major ... in the treatment of patients with refractory ascites due ... University of Vienna and Vienna General Hospital (AKH Wien) ... the ALFApump System were performed at Vienna General Hospital ...
Cached Biology Technology:Jennerex Presents Final Data From JX-594 Randomized Phase 2 Clinical Trial Showing Statistically Significant Survival Benefit in Patients With Advanced Liver Cancer 2Jennerex Presents Final Data From JX-594 Randomized Phase 2 Clinical Trial Showing Statistically Significant Survival Benefit in Patients With Advanced Liver Cancer 3Jennerex Presents Final Data From JX-594 Randomized Phase 2 Clinical Trial Showing Statistically Significant Survival Benefit in Patients With Advanced Liver Cancer 4Jennerex Presents Final Data From JX-594 Randomized Phase 2 Clinical Trial Showing Statistically Significant Survival Benefit in Patients With Advanced Liver Cancer 5Jennerex Presents Final Data From JX-594 Randomized Phase 2 Clinical Trial Showing Statistically Significant Survival Benefit in Patients With Advanced Liver Cancer 6Radient Pharmaceuticals Announces Proxy Resolutions Approved at Special Meeting of Stockholders 2The Medical University of Vienna and Vienna General Hospital Perform the First two Commercial Implants Worldwide of Sequana Medical's ALFApump® System 2
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... researchers from the UAB has found experimental evidence in ... the tendency to explore perseveringly. This is the first ... psychological characteristics, such as anxiousness, that might affect results. ... study are useful for planning preventative strategies in the ...
... wildly different species, evolution whizzes along. As different ... their environment and prosper. It happens in marine ... illustrates, in precancerous tumors, too. , In a ... Maley, Ph.D., a researcher at The Wistar Institute, ...
... to the human eye, but how does a sunflower ... daisy its delicate symmetry? , That was the question ... answered one of biology's enduring questions with an animated ... plants grow into recognizable shapes. , In the article ...
Cached Biology News:A link is found between morphine addiction and the tendency to explore 2A link is found between morphine addiction and the tendency to explore 3Evolutionary biology research techniques predict cancer 2Pleasing plant shapes explained by new computer model 2
...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (R3776) ... assistance. Material: cap polystyrene ...
... simple and convenient method for the rapid, thorough ... optimized for use with S. cerevisiae and C. ... species that is susceptible to yeast lytic enzyme ... of yeast cells that are ideal for both ...
Biology Products: